BUPRENORPHINE HYDROCHLORIDE
BUPRENORPHINE HYDROCHLORIDE
Approval overview BUPRENORPHINE HYDROCHLORIDE is listed in Drugs@FDA under application 219302 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient BUPRENORPHINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 0.3MG BASE/ML Sponsor SOMERSET THERAPS LLC Submission history Latest submission status date: 2025-12-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview BUPRENORPHINE HYDROCHLORIDE is listed in Drugs@FDA under application 219302 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BUPRENORPHINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 0.3MG BASE/ML Sponsor SOMERSET THERAPS LLC Submission history Latest submission status date: 2025-12-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.